US Patent 7750028 Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1, 2,3-triazole-4-carboxamide

Patent 7750028 was granted and assigned to Novartis on July, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

77500280

Patent Inventor Names

Walter Scherrer0

Martin Szelagiewicz0

Robert Portmann0

Urs C Hofmeier0

Andreas Burkhard0

Date of Patent

July 6, 2010

Patent Application Number

113299450

Date Filed

January 11, 2006

Patent Primary Examiner

‌

Celia Chang

Patent abstract

The invention relates to the novel modifications B and C of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of the formula

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7750028 Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1, 2,3-triazole-4-carboxamide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API